Physicians at the Heart Center of the University Hospital Bonn have revealed how communication between cells can be influenced using the protein hnRNPU, offering...
Eszter Nagy, CEO and founder of CEBINA, speaks about the multifaceted activities of the Central European Biotech Incubator and Accelerator, which has joined the...
The Innovation Platform spoke to Professor Sara Brucker, Executive Medical Director of the Department of Women's Health at the University Hospital and Faculty of...
A new Artificial Intelligence-based technology can help researchers better understand tumour formation and unravel cell signalling in response to cancer treatment.
Scientists at the Institute...
Researchers have developed a new blood test to help diagnose people with Alzheimer’s disease up to 20 years before the onset of cognitive impairment.
This...
Scientists at Nanyang Technological University (NTU) have successfully improved the speed, handling time, and cost of COVID-19 laboratory tests.
This new approach could result in...
Scientists led by the University of Birmingham, UK, have significantly improved the detection of adrenal cancer using a simple urine test.
Prior to this research,...
Scientists from the EU-funded VANGUARD project have received €6,844,625 to develop a bio-artificial lab-grown pancreas.
By developing an artificial lab-grown pancreas, the VANGUARD project aims...
Scientists from Uppsala University have characterised how changes in glioblastoma brain cancer cells influence the effect of different drugs.
Glioblastoma is a severe form of...
How industries have evolved and production has shifted during the pandemic to help fight the virus and find new market opportunities for the protection...
Mariano Votta, Director of Active Citizenship Network, speaks to The Innovation Platform about good practices to better address the societal impact of pain.
Chronic pain...
The García-Sastre laboratory focuses on viral host-pathogen interactions, vaccines, anti-viral drug development and cancer viroimmunotherapy to address global health threats.
In 1918 when WW1 was...
InhaTarget Therapeutics speaks to The Innovation Platform about their promising preclinical efficacy data on CIS-DPI product combined with ICIs.
In December 2018, we presented our...